With the goal of slowing or stopping the spread of Parkinson’s disease, UCSF researchers have developed genetically-engineered mice to test drugs and medical therapies.
Experts from industry, academia, and venture capital who have experience creating therapies and diagnostic tests will help the researchers outline appropriate next steps.